4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
7.79
-0.20 (-2.50%)
At close: Nov 22, 2024, 4:00 PM
7.78
-0.01 (-0.13%)
After-hours: Nov 22, 2024, 6:13 PM EST
4D Molecular Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$46.75
Upside
+500.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +400.64% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +362.13% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $39 | Buy | Maintains | $40 → $39 | +400.64% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 23, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +400.64% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Reiterates $40 → $36 | Buy | Reiterates | $40 → $36 | +362.13% | Sep 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +362.13% | Sep 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +362.13% | Aug 9, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +413.48% | Jul 22, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $63 → $40 | Buy | Maintains | $63 → $40 | +413.48% | Jul 18, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +387.80% | Jul 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $40 | Buy | Reiterates | $40 | +413.48% | Jun 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +362.13% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +362.13% | May 13, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $35 → $40 | Buy | Maintains | $35 → $40 | +413.48% | Apr 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.